[1]
Bhanwra, S. and Ahluwalia, K. 2020. Ubrogepant: a new era in migraine treatment. International Journal of Basic & Clinical Pharmacology. 9, 5 (Apr. 2020), 819–821. DOI:https://doi.org/10.18203/2319-2003.ijbcp20201766.